New York 2025-2026 Regular Session

New York Senate Bill S09278

Introduced
2/24/26  

Caption

Includes interest earned on the monies obtained by the state through the statewide opioid settlement agreement, in the opioid settlement fund; requires any New York subdivision that receives funds pursuant to an opioid settlement agreement to spend interest earned on such funds on approved uses.

Impact

The implications of S09278 on state law involve enhancing the existing framework governing the use of funds from opioid settlements. By clearly defining that both principal funds and their accrued interest will be allocated to the opioid settlement fund, the bill aims to safeguard these financial resources. This approach is seen as a positive step toward transparency and effective utilization of funds designated for addressing the public health crisis exacerbated by the opioid epidemic. However, the bill does not provide detailed guidelines on how the allocated funds are to be spent, which might raise questions about oversight and accountability.

Summary

S09278, introduced by Senator Fernandez, seeks to amend the state finance law specifically regarding the management of funds acquired through statewide opioid settlement agreements. The bill outlines that all money received from such settlements, including any earned interest, will be allocated to a designated fund that will remain untouched until directed by statute or appropriation. The intent behind this bill is to ensure that the financial resources from these settlements are appropriately contributed to a singular fund, streamlining how the funds are managed and utilized.

Contention

While the bill appears straightforward, it has sparked discussions regarding the broader implications of fund management for public health initiatives. Some legislators may argue that the lack of specific spending directives could lead to inefficient fund usage or a failure to address pressing local health needs. Additionally, there may be concerns that centralizing these funds without strict guidelines could reduce the flexibility required by local health authorities to respond to their unique challenges. Therefore, while the foundational aspects of the bill are supported for promoting financial clarity, the concerns regarding fund oversight and local health priorities remain points of contention.

Companion Bills

NY A10234

Same As Includes interest earned on the monies obtained by the state through the statewide opioid settlement agreement, in the opioid settlement fund; requires any New York subdivision that receives funds pursuant to an opioid settlement agreement to spend interest earned on such funds on approved uses.

Previously Filed As

NY A10234

Includes interest earned on the monies obtained by the state through the statewide opioid settlement agreement, in the opioid settlement fund; requires any New York subdivision that receives funds pursuant to an opioid settlement agreement to spend interest earned on such funds on approved uses.

NY A08997

Requires the report on statewide opioid settlements include the amount of funds that have been spent and requires the public be provided information on how much funds have been spent.

NY A08459

Clarifies that certain provisions related to statewide opioid settlement agreements shall cover settlements and releases related to any entities involved in the prescription drug marketing, supply and payment chain that may have contributed to the opioid epidemic through illegal conduct.

NY S04639

Relates to reporting on funds received pursuant to a New York opioid settlement sharing agreement.

NY A06554

Relates to reporting on funds received pursuant to a New York opioid settlement sharing agreement.

NY HB1237

Use of opioid settlement funds.

NY H2293

Requiring municipal spending reports on the use of opioid settlement funds

NY HB848

Opioid Settlement Fund Committee; create to disburse opioid litigation settlement monies.

NY HB344

Opioid Settlement Fund

NY S06757

Clarifies that certain provisions related to statewide opioid settlement agreements shall cover settlements and releases related to any entities involved in the prescription drug marketing, supply and payment chain that may have contributed to the opioid epidemic through illegal conduct.

Similar Bills

No similar bills found.